436
LIU ET AL.
5 1.3 Hz, 1H, ArH), 6.29 (dd, J 5 1.8, 3.3 Hz, 1H, ArH), 78.3, 52.2, 43.6, 42.7, 33.1, 28.4, 25.0. HPLC (Chiralpak
6.18 (d, J 5 3.2 Hz, 1H, ArH), 4.80 (m, 1H, CH), 4.67 (dd, AD-H, i-propanol/hexane 5 10:90, flow rate 1.0 ml/min, k
J 5 8.9, 12.2 Hz, 1H, CH), 3.96 (dt, J 5 9.3 Hz, 1H, CH), 5 254 nm): tminor 5 9.46 min, tmajor 5 10.32 min; ee 5
2.75–2.73 (m, 1H, CH), 2.45–2.36 (m, 2H, CH2), 2.11–2.09 82%.
(m, 1H, CH), 1.84–1.61 (m, 4H, 23 CH2), 1.28–1.26 (m,
1H, CH); 13C NMR (100 MHz, CDCl3): d 210.9, 150.8,
142.3, 110.3, 108.9, 76.6, 51.0, 42.5, 37.5, 32.4, 28.2, 25.0.
(S)-2-((R)-2-Nitro-1-phenylethyl)cyclopentanone,
3M.10 1H NMR (400 MHz, CDCl3): d 7.28–7.20 (m, 3H,
ArH), 7.13–7.08 (m, 2H, ArH), 5.30–5.23 (m, 1H, CH), 4.95
(dd, J 5 9.9, 12.6 Hz, 1H, CH), 3.67–3.60 (m, 1H, CH),
2.34–2.25 (m, 2H, CH2), 2.10–2.06 (m, 1H, CH), 1.87–1.78
(m, 2H, CH2), 1.72–1.65 (m, 1H, CH), 1.53–1.37 (m, 1H,
CH); 13C NMR (100 MHz, CDCl3): d 218.5, 137.7, 137.4,
128.9, 128.5, 127.9, 78.3, 50.5, 44.2, 38.7, 28.3, 25.0. HPLC
(Chiralpak AD-H, i-propanol/hexane 5 10:90, flow rate 1.0
ml/min, k 5 254 nm): syn: tmajor 5 9.96 min, tminor 5 11.42
min, anti: tminor 5 12.90 min, tmajor 5 17.32 min; syn/anti
5 30:70; ee 5 95%.
HPLC (Chiralpak AD-H, i-propanol/hexane 5 10:90, flow
rate 1.0 ml/min, k 5 254 nm): tmajor510.22 min, tminor
12.40 min; ee 5 78%.
5
(S)-2-((R)-1-(3,4-Dimethoxyphenyl)-2-nitroethyl)
cyclohexanone, 3I.22 1H NMR (400 MHz, CDCl3): d
6.81 (d, J 5 8.2 Hz, 1H, ArH), 6.68 (m, 2H, ArH), 4.91 (dd,
J 5 4.6, 7.8 Hz, 1H, CH), 4.60 (dd, J 5 2.4, 9.9 Hz, 1H,
CH), 3.87 (s, 6H, 23 OCH3), 3.70 (m, 1H, CH), 2.66–2.64
(m, 1H, CH), 2.49–2.45 (m, 1H, CH), 2.41–2.38 (m, 1H,
CH), 2.07–2.04 (m, 1H, CH), 1.80–1.60 (m, 4H, 23 CH2),
1.27–1.23 (m, 1H, CH); 13C NMR (100 MHz, CDCl3):
d 212.2, 149.2, 148.6, 130.2, 120.5, 111.5, 79.1, 56.0,
52.7, 43.8, 42.6, 33.3, 28.5, 27.5, 25.1. HPLC (Chiralpak
As-H, i-propanol/hexane 5 30:70, flow rate 1.0 ml/min,
k 5 254 nm): tminor 5 12.31 min, tmajor 5 22.31 min;
ee 5 83%.
TABLE 1. Catalyst and solvent screening in the direct
asymmetric Michael reaction of cyclohexanone with
b-nitrostyrenea
(S)-2-((R)-1-(4-Trifluoromethyl)phenyl)-2-nitroethyl)-
cyclohexanone, 3J.44 1H NMR (400 MHz, CDCl3): d 7.59
(d, J 5 8.1 Hz, 2H, ArH), 7.30 (m, 2H, ArH), 4.98 (dd, J 5
4.5, 12.6 Hz, 1H, CH), 4.67 (dd, J 5 9.8, 12.2 Hz, 1H, CH),
3.86 (m, 1H, CH), 2.72–2.70 (m, 1H, CH), 2.51–2.47 (m,
1H, CH), 2.41–2.38 (m, 1H, CH), 2.11–2.07 (m, 1H, CH),
1.83–1.57 (m, 4H, 23 CH2), 1.27–1.23 (m, 1H, CH); 13C
NMR (100 MHz, CDCl3): d 211.8, 149.1, 136.9, 130.0,
121.7, 121.6, 78.9, 52.9, 42.7, 43.1, 33.6, 28.8, 25.5. HPLC
(Chiralpak AD-H, i-propanol/hexane 5 10:90, flow rate
1.0 ml/min, k 5 254 nm): tminor 5 9.81; tmajor 5 19.25 min;
ee 5 88%.
Yieldb
(%)
eec
(%)
drd
(syn/anti)
Entry
Catalyst
Solvent
Toluene
Neat
Toluene
Neat
Toluene
Neat
Toluene
Neat
Toluene
Toluene
Toluene
Toluene
Toluene
Toluene
Cyclohexane
DMF
CH3OH
C2H5OH
i-C3H7OH
H2O
1
2
3
4
5
6
7
8
A
A
B
B
C
C
D
D
C
C
C
C
C
C
C
C
C
C
C
C
50
70
57
66
90
69
Trace
45
62
47
44
58
74
40
Trace
Trace
12
Trace
28
91
97
96
94
98
93
2
85
97
98
96
98
98
99
–
91:9
96:4
93:7
92:8
95:5
92:8
2
84:16
95:5
94:6
97:3
95:5
95:5
97:3
–
9e
10f
11g
(S)-2-((R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-nitroethyl)
cyclohexanone, 3K.7 1H NMR (400 MHz, CDCl3): d 6.74
(d, J 5 7.9 Hz, 1H, ArH), 6.64–6.61 (m, 2H, ArH), 5.96 (s,
2H, OCH2O), 4.91 (dd, J 5 4.5, 12.4 Hz, 1H, CH), 4.54 12h
13i
(dd, J 5 4.5, 10.0 Hz, 1H, CH), 3.67 (dt, J 5 4.5, 9.9 Hz,
1H, CH), 2.63–2.58 (m, 1H, CH), 2.51–2.37 (m, 2H, CH2),
14j
15
16
17
2.15–2.07 (m, 1H, CH), 1.79–1.58 (m, 4H, 23 CH2), 1.35–
1.23 (m, 1H, CH2); 13C NMR (100 MHz, CDCl3): d 211.7,
–
94
–
88
96
–
92:8
–
85:15
93:7
148.0, 147.1, 131.2, 121.6, 108.5, 108.0, 101.2,
18
78.9, 52.5, 43.6, 42.6, 33.2, 28.3, 25.1. HPLC (Chiralpak
19
20
AD-H, i-propanol/hexane 5 10:90, flow rate 1.0 ml/min,
k 5 254 nm): tminor 5 16.56 min, tmajor 518.72 min;
ee 5 92%.
13
ab-Nitrostyrene (0.50 mmol), cyclohexanone (1.0 mmol), supported
catalyst A (45 mg, 5 mol % active loading), B (23 mg, 5 mol % active
loading), C (21 mg, 5 mol % active loading), or D (35 mg, 5 mol % active
loading) at room temperature (258C) for 72 h with vigorous stirring.
bIsolated yields.
(S)-2-((R)-1-(3-Bromophenyl)-2-nitroethyl)cyclo-
hexanone, 3L.44 1H NMR (400 MHz, CDCl3): d 7.40 (d,
J 5 7.7 Hz, 1H, ArH), 7.39 (s, 1H, ArH), 7.21 (t, J 5 7.9
Hz, 1H, ArH), 7.10 (d, J 5 7.2 Hz, 1H, ArH), 4.94 (dd, J 5
4.5, 12.7 Hz, 1H, CH), 4.60 (dd, J 5 10.0, 12.7 Hz, 1H,
CH), 3.77–3.71 (m, 1H, CH), 2.65–2.59 (m, 1H, CH), 2.48–
2.38 (m, 2H, CH2), 2.09–2.05 (m, 1H, CH), 1.79–1.56 (m,
4H, 23 CH2), 1.31–1.20 (m, 1H, CH); 13C NMR (100 MHz,
cDetermined by chiral HPLC analysis.
dDetermined by 1H NMR analysis.
eIn the presence of TFA (0.10 mmol).
fIn the presence of citric acid (0.10 mmol).
gIn the presence of TsOH (0.10 mmol).
hIn the presence of benzoic acid (0.10 mmol).
iIn the presence of catalyst C (11 mg, 2.5 mol % active loading).
CDCl3): d 211.2, 140.1, 131.2, 130.9, 130.4, 126.9, 122.8, jAt 08C.
Chirality DOI 10.1002/chir